Published in J Clin Pharmacol on July 17, 2009
Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease. AAPS J (2009) 1.48
Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents. Br J Pharmacol (2010) 1.10
Application of quantitative pharmacology in development of therapeutic monoclonal antibodies. AAPS J (2010) 0.84
Population PK/PD analysis of metformin using the signal transduction model. Br J Clin Pharmacol (2012) 0.78
Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis. Clin Cosmet Investig Dermatol (2010) 0.76
Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis. Pharm Res (2017) 0.75
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med (2011) 6.85
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum (2004) 6.22
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum (2007) 3.32
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum (2006) 3.29
The dragon strikes: lessons from the Wenchuan earthquake. Anesth Analg (2010) 2.78
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum (2008) 2.75
Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999. Pharmacoepidemiol Drug Saf (2002) 2.71
Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther (2002) 2.58
Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum (2009) 2.49
Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum (2008) 2.48
A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs. Nat Biotechnol (2007) 2.35
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis (2010) 2.34
Identifying gene-disease associations using centrality on a literature mined gene-interaction network. Bioinformatics (2008) 2.32
Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol (2005) 2.27
The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy. Arthritis Rheum (2011) 2.10
Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J Immunol Methods (2002) 2.04
Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum (2008) 2.02
Risk of childhood undernutrition related to small-for-gestational age and preterm birth in low- and middle-income countries. Int J Epidemiol (2013) 2.00
MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis (2011) 1.90
The link between obesity and the built environment. Evidence from an ecological analysis of obesity and vehicle miles of travel in California. Health Place (2005) 1.77
Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J Biol Chem (2002) 1.72
Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors. Cancer (2007) 1.68
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis. Eur J Clin Pharmacol (2009) 1.67
Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol (2004) 1.66
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis. J Clin Pharmacol (2007) 1.62
The natural history of spondylolysis and spondylolisthesis: 45-year follow-up evaluation. Spine (Phila Pa 1976) (2003) 1.59
Drug prescribing indicators in village health clinics across 10 provinces of Western China. Fam Pract (2010) 1.57
Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis. Clin Vaccine Immunol (2007) 1.50
Cluster analysis of gene expression data based on self-splitting and merging competitive learning. IEEE Trans Inf Technol Biomed (2004) 1.49
Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity. Phytomedicine (2012) 1.48
Identification of the Xenopus DNA2 protein as a major nuclease for the 5'->3' strand-specific processing of DNA ends. Nucleic Acids Res (2008) 1.47
High Caesarean section rate in rural China: is it related to health insurance (New Co-operative Medical Scheme)? Soc Sci Med (2012) 1.47
SCS: signal, context, and structure features for genome-wide human promoter recognition. IEEE/ACM Trans Comput Biol Bioinform (2010) 1.44
Factors influencing internet addiction in a sample of freshmen university students in China. Cyberpsychol Behav (2009) 1.44
Population pharmacokinetics of infliximab in patients with ankylosing spondylitis. J Clin Pharmacol (2008) 1.43
Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis (2010) 1.43
Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol (2009) 1.42
Bioanalytical interferences in immunoassays for antibody biotherapeutics. Bioanalysis (2011) 1.41
Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial. Arthritis Rheum (2012) 1.40
Double-blinded infliximab dose escalation in patients with rheumatoid arthritis. Ann Rheum Dis (2007) 1.37
Infliximab treatment maintains employability in patients with early rheumatoid arthritis. Arthritis Rheum (2006) 1.36
Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function. J Immunol Methods (2004) 1.34
Identification of residues responsible for ligand recognition and regioisomeric selectivity of lysophosphatidic acid receptors expressed in mammalian cells. J Biol Chem (2005) 1.34
Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China. J Antimicrob Chemother (2008) 1.32
A novel vessel segmentation algorithm for pathological retina images based on the divergence of vector fields. IEEE Trans Med Imaging (2008) 1.29
Microarray missing data imputation based on a set theoretic framework and biological knowledge. Nucleic Acids Res (2006) 1.28
Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. Clin Cancer Res (2007) 1.27
Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. Arthritis Rheum (2008) 1.27
Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study. Arthritis Rheum (2010) 1.27
An adaptive spatial fuzzy clustering algorithm for 3-D MR image segmentation. IEEE Trans Med Imaging (2003) 1.25
Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol (2007) 1.24
Local and target-derived brain-derived neurotrophic factor exert opposing effects on the dendritic arborization of retinal ganglion cells in vivo. J Neurosci (2002) 1.24
Alpha-v integrins as therapeutic targets in oncology. Cancer Invest (2007) 1.22
Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit (2008) 1.22
Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol (2007) 1.22
Scientific and regulatory considerations on the immunogenicity of biologics. Trends Biotechnol (2006) 1.21
Missing value imputation for gene expression data: computational techniques to recover missing data from available information. Brief Bioinform (2010) 1.19
(+/-)-3-Oxocyclopentanecarboxylic acid: The smallest keto acid known to aggregate by catemeric hydrogen bonding. Acta Crystallogr C (2006) 1.18
Validity and reproducibility of a semi-quantitative food frequency questionnaire for use among pregnant women in rural China. Asia Pac J Clin Nutr (2008) 1.18
Mechanistic analysis of a DNA end processing pathway mediated by the Xenopus Werner syndrome protein. J Biol Chem (2006) 1.17
Discovering biclusters in gene expression data based on high-dimensional linear geometries. BMC Bioinformatics (2008) 1.16
Activation of DSB processing requires phosphorylation of CtIP by ATR. Mol Cell (2012) 1.16
A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China. BMC Gastroenterol (2010) 1.16
Effects of maternal multimicronutrient supplementation on the mental development of infants in rural western China: follow-up evaluation of a double-blind, randomized, controlled trial. Pediatrics (2009) 1.16
Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study. Ann Rheum Dis (2011) 1.16
Interspecies scaling of therapeutic monoclonal antibodies: initial look. J Clin Pharmacol (2009) 1.15
Utilization of delivery care among rural women in China: does the health insurance make a difference? a cross-sectional study. BMC Public Health (2010) 1.14
Pharmacokinetic and pharmacodynamic modeling of an anti-interleukin-6 chimeric monoclonal antibody (siltuximab) in patients with metastatic renal cell carcinoma. Clin Cancer Res (2010) 1.13
Titin and diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.13
Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants. J Immunol Methods (2004) 1.12
Preliminary evidence for a 1000-year-old tsunami in the South China Sea. Sci Rep (2013) 1.12
Whole genome association mapping of Fusarium head blight resistance in European winter wheat (Triticum aestivum L.). PLoS One (2013) 1.12
Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects. DNA Cell Biol (2005) 1.11
Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials. Clin Ther (2011) 1.11
Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction (2011) 1.10
Proofreading exonuclease activity of human DNA polymerase delta and its effects on lesion-bypass DNA synthesis. Nucleic Acids Res (2009) 1.10
Effect of a traditional Japanese herbal medicine, hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly persons. Int Immunopharmacol (2004) 1.08
The p38/MAPK pathway regulates microtubule polymerization through phosphorylation of MAP4 and Op18 in hypoxic cells. Cell Mol Life Sci (2009) 1.08
Comment on 'Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression'. J Obstet Gynaecol Res (2013) 1.08
Theoretical foundations for interventions designed to promote informed decision making for cancer screening. Ann Behav Med (2006) 1.08
Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis. Arthritis Rheum (2008) 1.08
Effect of iron deficiency anemia in pregnancy on child mental development in rural China. Pediatrics (2013) 1.07
Immunogenicity of therapeutic monoclonal antibodies. Curr Opin Mol Ther (2003) 1.07
Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis. J Clin Pharmacol (2005) 1.07